Discover
EW
Edwards Lifesciences Corporation
91.99
300 x undefined
200 x undefined
bid
ask
+
1.53
1.69%
250 @ 04:00 PM
93.76 +1.77 (1.92%)
| Ytd | 7.91% | |
| 1y | 19.19% |
90.28
day range
92.39
72.30
52 week range
92.88
| Open | 91.01 | Prev Close | 90.46 | Low | 90.28 | High | 92.39 | Mkt Cap | 52.97B |
| Vol | 3.30M | Avg Vol | 5.18M | EPS | 1.85 | P/E | 49.72 | Forward P/E | 27.32 |
| Beta | 0.87 | Short Ratio | 2.34 | Inst. Own | 94.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-23 | 50-d Avg | 84.93 | 200-d Avg | 82.36 | 1yr Est | 96.92 |
| Income Statement | |||
| Total Revenue | 1.65B | ||
| Revenues (USD) | 1.65B | ||
| Cost of Revenue | 362.60M | ||
| Gross Profit | 1.29B | ||
| Operating Expenses | 932.00M | ||
| Research and Development Expense | 263.30M | ||
| Selling, General and Administrative Expense | 522.20M | ||
| Operating Income | 354.00M | ||
| Income Tax Expense | 78.30M | ||
| Net Income | 380.70M | ||
| Net Income Common Stock | 380.70M | ||
| Net Income Common Stock (USD) | 380.70M | ||
| Consolidated Income | 380.70M | ||
| Earnings per Basic Share | 0.66 | ||
| Earnings per Basic Share (USD) | 0.66 | ||
| Earnings per Diluted Share | 0.66 | ||
| Earning Before Interest & Taxes (EBIT) | 459.00M | ||
| Earning Before Interest & Taxes (USD) | 459.00M | ||
| Weighted Average Shares | 579.20M | ||
| Weighted Average Shares Diluted | 580.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.45B | ||
| Cash and Equivalents (USD) | 2.45B | ||
| Investments | 1.51B | ||
| Investments Current | 1.23B | ||
| Investments Non-Current | 285.60M | ||
| Trade and Non-Trade Receivables | 973.00M | ||
| Current Assets | 6.23B | ||
| Property, Plant & Equipment Net | 1.92B | ||
| Total Assets | 13.32B | ||
| Debt Current | 24.30M | ||
| Total Debt | 702.90M | ||
| Current Liabilities | 1.41B | ||
| Debt Non-Current | 678.60M | ||
| Total Liabilities | 2.99B | ||
| Accumulated Retained Earnings (Deficit) | 14.62B | ||
| Accumulated Other Comprehensive Income | -221.30M | ||
| Shareholders Equity | 10.33B | ||
| Shareholders Equity (USD) | 10.33B | ||
| Assets Non-Current | 7.09B | ||
| Total Debt (USD) | 702.90M | ||
| Goodwill and Intangible Assets | 3.05B | ||
| Inventory | 1.12B | ||
| Liabilities Non-Current | 1.58B | ||
| Trade and Non-Trade Payables | 1.38B | ||
| Tax Assets | 1.10B | ||
| Tax Liabilities | 555.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 47.40M | ||
| Net Cash Flow from Financing | -451.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -492.00M | ||
| Capital Expenditure | -64.90M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -41.40M | ||
| Issuance (Purchase) of Equity Shares | -352.90M | ||
| Net Cash Flow from Investing | -92.80M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 13.80M | ||
| Net Cash Flow from Operations | 43.80M | ||
| Effect of Exchange Rate Changes on Cash | 8.20M | ||
| Share Based Compensation | 45.40M | ||